Research Peptide Comparison
PT-141 10mg and Tesamorelin 10mg are both Research Peptides research peptides available from Neovia Peptides. This comparison highlights the key differences in specifications, pricing, and availability to help inform your research decisions.
PT-141 (Bremelanotide) is a cyclic heptapeptide melanocortin-receptor agonist with primary activity at the MC3R and MC4R subtypes, exerting its effects through central nervous system signalling rather than peripheral vascular pathways. This mechanism has placed it at the centre of research into central arousal circuits, sexual health pharmacology and melanocortin-system pharmacology more broadly.
Compared to Tesamorelin 10mg, PT-141 10mg is priced at £16.99 with 99%+ verified purity. Its CAS registry number is 189691-06-3. It has a molecular weight of 1025.18 g/mol.
PT-141 10mg is available in single size and ships with a full Certificate of Analysis from Janoshik Analytical. At £48.00 less than Tesamorelin 10mg, it is the more affordable option in this comparison.
Tesamorelin is a 44-amino-acid GHRH analog stabilised by a trans-3-hexenoic acid modification that resists dipeptidyl peptidase-IV cleavage, supporting sustained receptor engagement and prolonged IGF-1 elevation. It is among the most extensively characterised GHRH analogs in the visceral adiposity and metabolic-modulation literature.
Compared to PT-141 10mg, Tesamorelin 10mg is priced at £64.99 with 99%+ verified purity. Its CAS registry number is 218949-48-5. It has a molecular weight of 5135.90 g/mol.
Tesamorelin 10mg is available in 5mg, 10mg and ships with a full Certificate of Analysis from Janoshik Analytical. It is priced £48.00 higher than PT-141 10mg.
All products sold by Neovia Peptides are strictly for in-vitro research and laboratory use only. Not intended for human or veterinary use, food additives, drugs, or cosmetics. By purchasing from this website, you agree that you understand and accept these terms.
